VSee Health Announces $935K Contracts with Major Medical Device Manufacturers
VSee Health (NASDAQ: VSEE) has secured contracts worth $935,000 with several medical technology solution companies. The company's platform enables healthcare equipment and device manufacturers to provide remote support and operation of their products, featuring Uber-like routing to support agents, high-fidelity screen sharing, and remote device control capabilities.
The platform offers specific features including one-click routing for customer service access, remote biomedical technician operations, lossless screen sharing for medical imaging, HIPAA-compliant infrastructure, and FDA embedding-ready integration. VSee's infrastructure has been field-tested on 1.5M monthly virtual encounters and is certified by third-party cybersecurity auditors.
This expansion into the medical technology sector aligns with the industry's projected growth to $800 billion by 2030, positioning VSee to capitalize on healthcare providers' increasing adoption of advanced imaging systems, robotics, and AI-enabled solutions.
VSee Health (NASDAQ: VSEE) ha ottenuto contratti del valore di $935.000 con diverse aziende di soluzioni tecnologiche medicali. La piattaforma dell'azienda consente ai produttori di attrezzature e dispositivi medici di fornire supporto remoto e operazioni sui loro prodotti, con un sistema di instradamento simile a Uber per gli agenti di supporto, condivisione dello schermo ad alta fedeltà e capacità di controllo remoto dei dispositivi.
La piattaforma offre funzionalità specifiche tra cui instradamento con un clic per l'accesso al servizio clienti, operazioni remote da parte di tecnici biomedicali, condivisione dello schermo senza perdita di dati per l'imaging medico, infrastruttura conforme a HIPAA e integrazione pronta per l'FDA. L'infrastruttura di VSee è stata testata sul campo in 1,5 milioni di incontri virtuali mensili ed è certificata da auditor di cybersicurezza di terze parti.
Questa espansione nel settore della tecnologia medica si allinea con la crescita prevista dell'industria, che raggiungerà $800 miliardi entro il 2030, posizionando VSee per capitalizzare sull'adozione crescente da parte dei fornitori di servizi sanitari di sistemi di imaging avanzati, robotica e soluzioni abilitate all'AI.
VSee Health (NASDAQ: VSEE) ha conseguido contratos por un valor de $935,000 con varias empresas de soluciones tecnológicas médicas. La plataforma de la compañía permite a los fabricantes de equipos y dispositivos de atención médica brindar soporte y operación remota de sus productos, con un enrutamiento similar a Uber para los agentes de soporte, compartición de pantalla de alta fidelidad y capacidades de control remoto de dispositivos.
La plataforma ofrece características específicas que incluyen enrutamiento de un clic para el acceso al servicio al cliente, operaciones remotas de técnicos biomédicos, compartición de pantalla sin pérdida para imágenes médicas, infraestructura compatible con HIPAA e integración lista para la FDA. La infraestructura de VSee ha sido probada en el campo con 1.5 millones de encuentros virtuales mensuales y está certificada por auditores de ciberseguridad de terceros.
Esta expansión en el sector de la tecnología médica se alinea con el crecimiento proyectado de la industria, que alcanzará $800 mil millones para el 2030, posicionando a VSee para capitalizar la creciente adopción por parte de los proveedores de atención médica de sistemas de imagen avanzada, robótica y soluciones habilitadas para IA.
VSee Health (NASDAQ: VSEE)는 여러 의료 기술 솔루션 회사와 $935,000 규모의 계약을 체결했습니다. 회사의 플랫폼은 의료 장비 및 기기 제조업체가 원격 지원 및 제품 운영을 제공할 수 있도록 하며, 지원 담당자를 위한 우버와 같은 경로 설정, 고충실도 화면 공유 및 원격 장치 제어 기능을 제공합니다.
플랫폼은 고객 서비스 접근을 위한 원클릭 경로 설정, 원격 생명공학 기술자 작업, 의료 이미징을 위한 손실 없는 화면 공유, HIPAA 준수 인프라 및 FDA 통합 준비 기능 등 특정 기능을 제공합니다. VSee의 인프라는 매달 150만 건의 가상 만남에서 현장 테스트를 거쳤으며, 제3자 사이버 보안 감사 기관에 의해 인증받았습니다.
의료 기술 분야로의 이 확장은 산업이 2030년까지 $8000억에 이를 것으로 예상됨에 따라, VSee가 고급 이미징 시스템, 로봇 공학 및 AI 기반 솔루션의 증가하는 수용을 capitalizing 할 수 있는 위치를 차지하도록 하고 있습니다.
VSee Health (NASDAQ: VSEE) a obtenu des contrats d'une valeur de $935,000 avec plusieurs entreprises de solutions technologiques médicales. La plateforme de l'entreprise permet aux fabricants d'équipements médicaux et de dispositifs de fournir un support et un fonctionnement à distance de leurs produits, avec un routage similaire à celui d'Uber pour les agents de support, un partage d'écran de haute fidélité et des capacités de contrôle à distance des dispositifs.
La plateforme offre des fonctionnalités spécifiques, notamment un routage en un clic pour l'accès au service client, des opérations à distance par des techniciens biomédicaux, un partage d'écran sans perte pour l'imagerie médicale, une infrastructure conforme à la norme HIPAA et une intégration prête pour la FDA. L'infrastructure de VSee a été testée sur le terrain lors de 1,5 million de rencontres virtuelles mensuelles et est certifiée par des auditeurs de cybersécurité tiers.
Cette expansion dans le secteur des technologies médicales s'inscrit dans la croissance projetée de l'industrie, qui devrait atteindre $800 milliards d'ici 2030, plaçant VSee en position de capitaliser sur l'adoption croissante par les fournisseurs de soins de santé de systèmes d'imagerie avancée, de robotique et de solutions alimentées par l'IA.
VSee Health (NASDAQ: VSEE) hat Verträge im Wert von $935.000 mit mehreren Unternehmen für Medizintechnologielösungen abgeschlossen. Die Plattform des Unternehmens ermöglicht es Herstellern von medizinischen Geräten und Ausrüstungen, Fernsupport und den Betrieb ihrer Produkte anzubieten, und nutzt ein Uber-ähnliches Routing für Supportmitarbeiter, hochauflösendes Bildschirmsharing und Fernsteuerungsfunktionen von Geräten.
Die Plattform bietet spezifische Funktionen, darunter Ein-Klick-Routing für den Kundenservice, Fernoperationen durch biomedizinische Techniker, verlustfreies Bildschirmsharing für medizinische Bilder, HIPAA-konforme Infrastruktur und FDA-bereit integrierte Lösungen. Die Infrastruktur von VSee wurde in 1,5 Millionen virtuellen Begegnungen pro Monat getestet und ist von unabhängigen Cybersecurity-Prüfern zertifiziert.
Diese Expansion in den Medizintechniksektor steht im Einklang mit dem prognostizierten Wachstum der Branche, das bis 2030 $800 Milliarden erreichen soll, und positioniert VSee, um von der zunehmenden Akzeptanz fortschrittlicher Bildgebungssysteme, Robotik und KI-gestützter Lösungen durch medizinische Dienstleister zu profitieren.
- Secured new contracts worth $935,000 with medical technology companies
- Platform successfully handles 1.5M monthly virtual encounters
- Targeting medtech market projected to reach $800B by 2030
- HIPAA-compliant and FDA embedding-ready infrastructure
- None.
Insights
The
The company's 'lego-like' modular platform approach is particularly compelling from a scalability and margin perspective. By offering remote support capabilities, VSee helps medical device manufacturers reduce their operational costs while potentially creating sticky, long-term customer relationships that could generate predictable revenue streams.
The most intriguing aspect is VSee's FDA embedding-ready status and HIPAA compliance, which creates significant barriers to entry. With 1.5M monthly virtual encounters, the platform demonstrates proven scalability. However, investors should note that while this represents a promising pivot, the relatively small contract value suggests this is still in early stages.
VSee's platform addresses critical pain points in medical device support that have historically required expensive on-site technicians. The Uber-like routing system for technical support combined with remote control capabilities could significantly reduce device downtime and support costs - a major consideration for healthcare facilities investing in expensive equipment.
The lossless screen sharing feature is particularly valuable for advanced medical imaging systems where diagnostic quality cannot be compromised. This, coupled with the ability to remotely operate complex equipment, could revolutionize how biomedical support is delivered, especially beneficial for facilities in remote locations or during off-hours.
The FDA embedding-ready status is a important differentiator, as medical device manufacturers often face significant regulatory hurdles when implementing third-party solutions. VSee's existing FDA compliance track record could accelerate adoption among major manufacturers looking to enhance their service offerings.
“Our partnerships with these medtech leaders highlight VSee’s ability to solve critical challenges in the medical technology industry,” stated Dr. Milton Chen, Co-CEO of VSee Health. “Our platform empowers healthcare equipment and device companies to deliver exceptional services including remote support and remote operation of their products, resulting in increased client ROI and significant cost reductions.”
VSee is recognized for its deep technology and extensive capabilities. It is distinct in its ability to power remote medical device workflows. Using its lego-like digital health building blocks, VSee uniquely addresses the needs of medical device manufacturers — from Uber-like routing to the next available support agent to high fidelity screen sharing and the remote control of the medical devices.
Enabling Remote Support and Remote Biomedical Technician Coverage
Medtech purchases are large investments for healthcare organizations. The VSee platform offers specific features that enable medical device companies to provide key value-adds to their customers:
- one-click, Uber-like routing - gives customers fast, convenient access to the appropriate customer service technician regarding a specific piece of medical equipment
- remote control and operations - gives customers the ability to staff with remote biomedical technicians to operate complex equipment from anywhere, anytime
- lossless screen sharing - allows remote viewing of advanced medical imaging
- secure, HIPAA-compliant infrastructure - utilizes the highest level of encryption, is field-tested on 1.5M monthly virtual encounters, and is certified by 3rd-party cybersecurity auditors
- FDA embedding-ready - VSee is successfully integrated with medical devices and submitted for combined FDA approval
VSee’s Growing Role in Medtech and Digital Health
The medtech industry is experiencing exponential growth, with the global market projected to reach
About VSee Health
VSee Health’s AI telehealth platform is the fastest way for enterprises to go from ideation to market go-live. Field-hardened on over 1.5M HIPAA-compliant video encounters every month, its customizable building blocks meet stringent government security standards, and are ready to scale. VSee Health has traveled for field deployments to over 50 countries such as
VSee Health offerings also include turnkey solutions for critical shortage areas such as critical care and teleradiology. It is committed to empowering high quality healthcare access and reducing physician burnout and workforce shortages through its telehealth technology. Visit vseehealth.com.
Forward-Looking Statements
This press release includes “forward-looking statements” within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Certain of these forward-looking statements can be identified by the use of words such as “believes,” “expects, “intends,” “plans,” “estimates,” “assumes,” “may,” “should,” “will,” “seeks,” or other similar expressions. Such statements may include, but are not limited to, statements regarding the Company’s ability to regain compliance with Nasdaq’s listing rules within the required timeframe. These statements are based on current expectations on the date of this press release and involve a number of risks and uncertainties that may cause actual results to differ significantly, including those risks set forth in the Company’s most recent Annual Report on Form 10-K and any subsequent Quarterly Reports on Form 10-Q and other documents filed with the SEC. Copies of such filings are available on the SEC’s website at www.sec.gov . The Company does not assume any obligation to update or revise any such forward- looking statements, whether as the result of new developments or otherwise. Readers are cautioned not to put undue reliance on forward-looking statements.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250121041228/en/
Media Contact:
VSee Health
Anne Chang
626-513-1824
media@vsee.com
Investor Contact:
Dave Gentry
RedChip Companies
1-407-644-4256
Source: VSee Health, Inc.
FAQ
What is the value of VSee Health's (VSEE) new medical device manufacturer contracts?
How many monthly virtual encounters does VSee's (VSEE) platform handle?
What are the key features of VSee's (VSEE) medical device platform?
What is the projected market size for medical technology that VSee (VSEE) is targeting?
